Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Nasal & Pulmonary Drug Development
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025
Bespak – 21.05.2025
Stoelzle – 15th May 2025

The Growing Prominence and Need of Patient Reported Outcomes

The challenge for pharmaceutical commercialisation no longer ends with regulatory approval; it intensifies after the approval. Today there is greater awareness about the benefit and risk of products, not only among healthcare professionals (HCPs), but also among consumers and the payers. Chitra Lele, Chief Scientific Officer at Sciformix Corporation, shares her thoughts about the need for patient-reported outcomes, and their growing prominence, by submitting a white paper on considerations for measurement, analysis and interpretation of data.

[su_document url=”https://international-pharma.com/wp-content/uploads/2015/04/03.-The-Growing-Prominence-and-Need.pdf” height=”980″ responsive=”no”]

Scott Pharma – 25.03.2025
SMI – 24/03/2025
Chemspec Europe – 27.02.2025
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
L.B. Bohle – 08.04.2025